Analyst Price Target is $593.00
▲ +14.85% Upside Potential
This price target is based on 1 analysts offering 12 month price targets for Chemed in the last 3 months. The average price target is $593.00, with a high forecast of $610.00 and a low forecast of $576.00. The average price target represents a 14.85% upside from the last price of $516.32.
Current Consensus is
The current consensus among 1 investment analysts is to buy stock in Chemed. This Buy consensus rating has held steady for over two years.
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in two segments, VITAS and Roto-Rooter. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees. The company was incorporated in 1970 and is headquartered in Cincinnati, Ohio.